Rubinstein Lab OSUCCC – James

The Rubinstein Lab is focused on developing immune-based strategies for the treatment of cancer and human disease.

Shared Resources OSUCCC – James

Translational Therapeutics Research Program Members

Claire VERSCHRAEGEN, Director of Medical Oncology, The Ohio State University, OH, OSU, The James Comprehensive Cancer Center

Biochemistry, University of Toronto – John L. Rubinstein

Clinical Trials Office

Jack Rubinstein, MD UC Health Provider Profile

Email - The Pelotonia Institute for Immuno-Oncology Spring 2020 Newsletter - Ohio State University Comprehensive Cancer Center

MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer

Research @ UPIKE

Shared Resources OSUCCC – James

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts, Journal for ImmunoTherapy of Cancer

Director's Welcome, Internal Medicine

COVID-19 mRNA Booster Vaccines Elicit Strong Protection Against SARS-CoV-2 Omicron Variant in Patients with Cancer

Email - The Pelotonia Institute for Immuno-Oncology Spring 2020 Newsletter - Ohio State University Comprehensive Cancer Center